Merck & Co., Inc. (MRK) Free cash flow 2016–2025
Merck & Co., Inc. (MRK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$12.4BFY2025 · since FY2016: $8.8B → $12.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.4B | -31.7% |
| FY2024 | $18.1B | +97.9% |
| FY2023 | $9.1B | -37.8% |
| FY2022 | $14.7B | +69.6% |
| FY2021 | $8.7B | +48.9% |
| FY2020 | $5.8B | -42.2% |
| FY2019 | $10.1B | +21.2% |
| FY2018 | $8.3B | +82.1% |
| FY2017 | $4.6B | -47.9% |
| FY2016 | $8.8B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice